The following discussion and analysis of our financial condition and results of
operations should be read in conjunction with our unaudited financial statements
and related notes appearing elsewhere in this quarterly report. In addition to
historical financial information, the following discussion includes certain
forward-looking statements that reflect our plans, estimates and our current
views with respect to future events and financial performance. Forward-looking
statements are often identified by words like: believe, expect, estimate,
anticipate, intend, project and similar expressions, or words which, by their
nature, refer to future events. You should not place undue certainty on these
forward-looking statements, which apply only as of the date of this report.
Except as required by applicable law, including the securities laws of the
United States, we do not intend to update any of the forward-looking statements
to conform these statements to actual results.



New Business



On December 28, 2021, we entered into an asset purchase agreement (the "Purchase
Agreement") with Sapir Pharmaceuticals, Inc., a Delaware corporation ("Sapir"),
pursuant to which we purchased certain assets from Sapir used in connection with
the proprietary stabilized formulation of the Epigallocatechin-gallate (EGCG)
molecule (the "Business") in exchange for 1,000,000 shares of newly-designated
Series A preferred stock (the "Preferred Stock"). The closing of the acquisition
occurred simultaneous with the execution and delivery of the Purchase Agreement.



At the closing, the parties also executed and delivered a royalty agreement (the
"Royalty Agreement") pursuant to which we agreed to pay Sapir a royalty equal to
5% of the gross revenues realized from licenses or products generated or derived
from the Business.



Due to circumstances beyond the control of the parties, we were unable to
develop the Business to the extent contemplated by (i) the Purchase Agreement
and the Royalty Agreement (together, the "Sapir Agreements") and (ii)
discussions that occurred between us and Sapir following the closing of the
Purchase Agreement. As a result, on June 6, 2022, we entered into a rescission
agreement with Sapir (the "Rescission Agreement") in order to rescind the
Purchase Agreement and the Royalty Agreement and restore both us and Sapir to
the respective positions we occupied immediately in advance of the execution and
delivery of the Sapir Agreements.



As of the date of the Rescission Agreement, we had not completed the issuance of the Preferred Stock to Sapir or completed any payments to Sapir under the Royalty Agreement.





In connection with the Sapir transaction, on January 14, 2022, we entered into a
settlement and termination agreement (the "Settlement Agreement") with Lode Star
Gold, Inc., a private Nevada corporation and our former controlling shareholder
("LSG"), in order to terminate the mineral option agreement between the parties
dated October 4, 2014, as amended on October 31, 2019 (together, the "Option
Agreement"). The Settlement Agreement provided for the immediate termination of
the Option Agreement (with the exception of certain standard provisions that
survived according to their terms); the forgiveness by LSG of all amounts owing
by us to LSG thereunder, which includes approximately $2.224 million in accrued,
unpaid penalty and other payments (collectively, the "Debt"); and the return to
LSG of our 20% undivided interest in and to the mineral property that was the
subject of the Option Agreement.



On June 8, 2022, and in connection with the rescission of the Sapir Agreements,
we entered into a debt reinstatement agreement (the "Reinstatement Agreement")
with LSG pursuant to which we agreed to reinstate the Debt. Also on June 8,
2022, we entered into debt conversion agreements with three related parties,
including LSG, pursuant to which the creditors converted an aggregate of
$2,601,207.55 in accrued, unpaid debt into 70,302,906 shares of our common stock
at a price of $0.037 per share.



Funding


At present we have no sustainable financing in place other than remedial expenses still being advanced by LSG.



                                       12



ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS


        OF OPERATIONS (continued)




Personnel



We have no employees. Apart from quarterly consulting fees, our President and
CEO, Mark Walmesley, receives no compensation for his services. We expect to
continue to use outside consultants, advisors, attorneys and accountants as
necessary.



Our CFO and Corporate Secretary, Samuel Sternheim, also receives no compensation for his services.





 Going Concern



There is substantial doubt that we can continue as an on-going business for the
next twelve months unless we obtain additional capital to pay our expenses. This
is because we have not generated any revenues to-date and we cannot currently
estimate the timing of any possible future revenues. Our only source of cash at
this time is from loans.



Results of Operations


The following summary of our results of operations should be read in conjunction with our financial statements for the period ended June 30, 2022 which are included above in Part I, Item 1.





                           Three Months Ended June 30                   Change
                              2022               2021          Amount         Percentage
                                $                 $               $
Revenue                                -               -               -                -
Operating Expenses                99,546          82,788          16,758               20 %
Operating Loss                   (99,546 )       (82,788 )       (16,758 )             20 %
Other Income (Expense)         2,186,682         (24,257 )     2,210,939            9,115 %
                               2,087,136        (107,045 )     2,194,181            2,050 %

                            Six Months Ended June 30                    Change
                              2022               2021          Amount         Percentage
                                $                 $               $
Revenue                                -               -               -                -
Operating Expenses               132,893         186,918          54,025              (29 %)
Operating Loss                  (132,893 )      (186,918 )       (16,758 )            (29 %)
Other Income (Expense)        2,186, 110         (47,007 )     2,233,117            4,750 %
                               2,053,217        (233,925 )     2,194,181              938 %




Revenues


We had no operating revenues during the three-month and six-month periods June 30, 2022 and 2021. We recorded a net income of $2,186,682 for the current quarter (2021: 47,007 net loss).





Expenses


Notable year over year differences in expenses for the second quarter in 2022 compared to 2021 are as follows:





                                             Three Months Ended June 30               Increase/(Decrease)
                                              2022                2021              Amount          Percentage
                                                $                   $                 $
Consulting services                              52,074              31,187            20,867                67 %
Exploration and evaluation                            -              13,158           (13,158 )            (100 %)
Mineral option fees                                   -              25,012           (25,012 )            (100 %)
Professional fees                                45,164               7,953            37,211               468 %

Interest, bank and finance charges                  235              24,257

          (24,022 )             (99 %)


                                       13


ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS


        OF OPERATIONS (continued)



Consulting services expense was higher during the second quarter of 2022 primarily due a late recorded invoice from the previous quarter.


Exploration and evaluation expense and mineral option fees were reduced to $Nil
in the first quarter of 2022 due to the Company terminating its mineral property
option and no longer spending on mining efforts.



Professional fees in the second quarter of 2022 included legal and bookkeeping
were increased as the Company paid its OTC Markets annual fee and continued to
restructure itself following the rescinding of the Sapir Pharmaceutical
transaction.



Interest, bank and finance charges were lower primarily due to the write down in loans from LSG and other related parties.

Notable year over year differences in expenses for the six month period ended June 30, 2022 compared to 2021 are as follows:





                                     Six Months Ended June 30               Increase/(Decrease)
                                      2022               2021             Amount          Percentage
                                       $                  $                 $
Exploration and evaluation                   -             20,689           (20,689 )            (100 %)
Mineral option fees                          -             49,988           (49,988 )            (100 %)
Professional fees                       52,254              7,953            44,301               557 %



Consulting services expense was higher during the second quarter of 2022 primarily due a late recorded invoice from the previous quarter.


Exploration and evaluation expense and mineral option fees were reduced to $Nil
in the six month period ended June 30, 2022 due to the Company terminating its
mineral property option and no longer spending on mining efforts.



Professional fees in the six month period ended June 30, 2022 included legal and
bookkeeping were increased as the Company paid its OTC Markets annual fee and
continued to restructure itself following the rescinding of the Sapir
Pharmaceutical transaction.

© Edgar Online, source Glimpses